Advanced Search
Title
Company
Description

Location:

Focus Search:

in house attorney
statistical programmer
pharmacokinetics
drug safety
pharmacovigilance
biometrics
preclinical
rna
cns
icf
modeling and simulation
toxicology
drug development
norton
gcp
pharmacology
regulatory affairs
life science
biopharmaceutical
clinical trials

Alnylam

Company

Headquarters:

Cambridge, MA
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

Similar companies:

AKCEA TherapeuticsIonis PharmaceuticalsMODERNASarepta TherapeuticsVertex Pharmaceuticals

CEO:

John Maraganore

Employees number:

> 500 (2017)

Subsidiaries:

Regulus Therapeutics Inc.Alnylam Europe AG
Active Date
  • Relevance
  • Active Date
All Jobs
  • All Jobs
  • Active
3,853 Jobs
Associate Director, Attorney
Alnylam PharmaceuticalsCambridge, MA
Associate Director, LegalOverviewAlnylam is the world's leading RNA interference (RNAi) company.
Full-time
Last updated 45 minutes ago
Principal Statistical Programmer
AlnylamCambridge, MA
Principal Statistical Programmer Overview Alnylam is the world's leading RNA interference (RNAi) company.Last updated 50 minutes ago
Associate Director, Pharmacometrics
AlnylamCambridge, MA
We are a growing biopharmaceutical company with three approved medicines and a robust pipeline of investigational medicines focused in four strategic therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases, including several in late-stage development.Last updated 53 minutes ago
Sr. Director, Clinical Operations
Alnylam PharmaceuticalsCambridge, MA
We are a growing biopharmaceutical company with two approved medicines and a robust pipeline of investigational medicines focused in four strategic therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases, including several in late-stage development.
Full-time
Last updated 2 hours ago
Manager, Regulatory Affairs
Alnylam PharmaceuticalsPhiladelphia, PA
Description Manager, Regulatory AffairsOverviewAlnylam is the world s leading RNA interference (RNAi) company.Last updated 5 hours ago
Associate Director, Regulatory Affairs
Alnylam PharmaceuticalsPhiladelphia, PA
Description Associate Director Regulatory Affairs, US TTR LeadOverviewAlnylam is the worlds leading RNA interference (RNAi) company.
Full-time
Last updated 5 hours ago
Manufacturing Associate
Alnylam Pharmaceuticals, Inc.Cambridge, MA
OverviewAlnylam is the world's leading RNA interference (RNAi) company.
Full-time
Last updated 5 hours ago
Director, National Accounts Lead- West
Alnylam PharmaceuticalsPhoenix, AZ
This position reports to the VP, Market Access and is field based.Last updated 6 hours ago
Manager, Regulatory Affairs, Global Labeling Operations
Alnylam PharmaceuticalsCambridge, MA
Manager, Regulatory Affairs, Global Labeling OperationsOverviewAlnylam is the world's leading RNA interference (RNAi) company.Last updated 6 hours ago
Associate Director, Pharmacometrics
Alnylam PharmaceuticalsCambridge, MA
We are a growing biopharmaceutical company with three approved medicines and a robust pipeline of investigational medicines focused in four strategic therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases, including several in late-stage development.Last updated 6 hours ago
Senior Manager, Statistical Programming
Alnylam Pharmaceuticals, Inc.Cambridge, MA
Senior Manager Statistical Programming Overview Alnylam was founded in 2002 on a revolutionary vision and bold mission which remain firmly in place today.Last updated 6 hours ago
Manager, Clinical Operations
Alnylam PharmaceuticalsSomerville, MA
We are a growing biopharmaceutical company with two approved medicines and a robust pipeline of investigational medicines focused in four strategic therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases, including several in late-stage development.Last updated 6 hours ago
12345Next »

Sponsored jobs: